Group items tagged

New immune system-boosting cancer drugs have in clinical trials saved the lives of many people with seemingly untreatable melanoma or lung cancer, but the drugs seem useless against colon cancer. One exception-a man with colon cancer whose metastatic tumors vanished for several years after he was treated in 2007-piqued researchers' interest. They suspected his recovery might have to do with the large number of mutations in his tumors. Now, a small clinical trial suggests that even cancer patients with types of tumors that were thought to be impervious to the new drugs could benefit if those malignancies have the right error-riddled DNA signature, a result that could help 3% to 4% of cancer patients.

Highlighting role of animal research in human health.  A visually appealing website with an array of research summaries.

The US Food and Drug Administration has approved a first-of-a-kind drug that uses the herpes virus to infiltrate deadly skin cancer tumours, reducing their size in some cases.